Jim Cramer Shared His Weekly Game Plan: 22 Stocks in Focus

7. Danaher Corporation (NYSE:DHR)

Number of Hedge Fund Holders: 117

Danaher Corporation (NYSE:DHR) is one of the stocks in focus as Jim Cramer shared his weekly game plan. Cramer expects positive things from the company’s upcoming quarterly earnings report, as he remarked:

CNBC Investing Club members, look out. You’re going to be flooded with emails Wednesday because Charitable Trust holdings, Danaher, Starbucks, GE Vernova, Microsoft, Meta, and Corning all report. Let me give you a preview. After a multi-year dry spell, Danaher has big orders from biotechs for expensive management. It seems like a biotech comes public every day, doesn’t it? They’ve managed some better-than-feared results in recent quarters, but this could be the first truly strong quarter in years. The stock was down badly today. Could be a real interesting opportunity.

Danaher Corporation (NYSE:DHR) provides instruments, consumables, software, and services used in bioprocessing, life sciences research, and clinical diagnostics. Cramer discussed the stock in detail during the episode aired on December 1, 2025, and said:

Now, first, there’s tried and true, but lately trying Danaher, DHR, a conglomerate that became more focused on life sciences diagnostics when it spun off its water and product quality testing business as Veralto a couple years ago. We own Danaher for the Charitable Trust. I gotta tell you, it’s been really frustrating for the past couple years, even though we bought it during the post-COVID washout. Turns out that was early, as the stock languished for a very long time. Lately, though, Danaher’s been acting much better. It’s up 31% from its April low. It’s up 25% from its more recent low… in September. Now get this, in late October, in the middle of the stock’s most recent rally, Danaher reported a strong quarter driven by solid growth numbers from the company’s crucial bioprocessing division, which had been so languishing. They posted a small revenue beat with a solid 3% organic growth, as well as a large earnings beat. While management merely reiterated their full-year sales and earnings forecast, that was enough to get the stock, I told you it’s been… in just a hell hole, get the stock moving higher. Looking ahead, Wall Street expects Danaher to put up its best growth in years in 2026, mid-single-digit revenue growth, and high single-digit earnings growth. If they can hit those targets, I bet the stock keeps running. I still like the stock for the Charitable Trust, but we bought some stock real low in this one, and I’m thinking of trimming it if the stock jumps another 10 points, but 10 could be a lot.